Stefania Catalano Selected Research

GW 4064

2/2016	Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy.
5/2013	Inhibition of Leydig tumor growth by farnesoid X receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy.
2/2010	Farnesoid X receptor, through the binding with steroidogenic factor 1-responsive element, inhibits aromatase expression in tumor Leydig cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefania Catalano Research Topics

Disease

64	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2003
51	Neoplasms (Cancer) 09/2021 - 08/2003
17	Obesity 01/2022 - 03/2009
9	Carcinogenesis 01/2020 - 04/2007
4	Inflammation (Inflammations) 07/2021 - 01/2020
3	Neoplasm Metastasis (Metastasis) 09/2020 - 10/2016
3	Insulin Resistance 03/2020 - 08/2011
2	Glioblastoma (Glioblastoma Multiforme) 09/2021 - 01/2020
2	Chronic Disease (Chronic Diseases) 07/2021 - 07/2021
2	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2021 - 01/2017
2	Disease Progression 03/2021 - 01/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2020 - 01/2020
2	Seminoma 01/2019 - 08/2012
2	Body Weight (Weight, Body) 05/2014 - 08/2003
2	Endometrial Neoplasms (Endometrial Cancer) 07/2012 - 03/2009
1	Metabolic Diseases (Metabolic Disease) 02/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Triple Negative Breast Neoplasms 12/2019

Drug/Important Bio-Agent (IBA)

24	Estrogens (Estrogen)FDA Link 09/2021 - 08/2003
21	LeptinIBA 07/2020 - 08/2003
16	LigandsIBA 09/2021 - 05/2004
16	Aromatase (CYP19)IBA 09/2021 - 08/2003
14	Proteins (Proteins, Gene)FDA Link 08/2020 - 05/2004
12	Estrogen ReceptorsIBA 09/2021 - 03/2012
12	Hormones (Hormone)IBA 08/2020 - 09/2005
10	CytokinesIBA 07/2021 - 04/2007
10	AdipokinesIBA 01/2020 - 11/2011
10	Estrogen Receptor alphaIBA 01/2020 - 05/2004
9	Biological ProductsIBA 07/2021 - 09/2005
8	ElementsIBA 07/2021 - 04/2007
7	PPAR gammaIBA 10/2020 - 09/2005
7	AndrogensIBA 01/2017 - 10/2009
7	Estradiol (Delestrogen)FDA LinkGeneric 01/2014 - 05/2004
6	Messenger RNA (mRNA)IBA 09/2021 - 05/2004
6	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2020 - 09/2005
6	Conditioned Culture MediaIBA 10/2020 - 01/2016
6	Antineoplastic Agents (Antineoplastics)IBA 09/2020 - 02/2016
6	Leptin ReceptorsIBA 07/2020 - 11/2011
6	EnzymesIBA 11/2019 - 02/2010
6	Cyclin D1IBA 05/2015 - 03/2009
5	AdiponectinIBA 01/2020 - 01/2014
4	Aromatase InhibitorsIBA 01/2022 - 01/2019
4	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 11/2019 - 01/2016
4	Tamoxifen FDA LinkGeneric 09/2015 - 10/2012
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 07/2021 - 06/2013
3	RetinoidsIBA 07/2021 - 01/2016
3	Dopamine (Intropin)FDA LinkGeneric 03/2020 - 11/2015
3	Docosahexaenoic AcidsIBA 03/2020 - 06/2013
3	Eicosapentaenoic AcidIBA 03/2020 - 06/2013
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 02/2010
3	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2019 - 10/2012
3	GW 4064IBA 02/2016 - 02/2010
3	Androgen Receptors (Androgen Receptor)IBA 04/2015 - 09/2010
3	Tyrosine (L-Tyrosine)FDA Link 01/2014 - 10/2009
2	Selective Estrogen Receptor Modulators (SERM)IBA 01/2022 - 01/2019
2	AntioxidantsIBA 07/2021 - 07/2021
2	Therapeutic UsesIBA 09/2020 - 08/2012
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 09/2020 - 10/2016
2	Insulin (Novolin)FDA Link 03/2020 - 01/2014
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 11/2019 - 01/2016
2	Peptides (Polypeptides)IBA 07/2019 - 05/2015
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2017
2	Protein Isoforms (Isoforms)IBA 01/2019 - 02/2014
2	Fas Ligand Protein (Fas Ligand)IBA 11/2017 - 02/2009
2	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 10/2016 - 01/2016
2	Co-Repressor ProteinsIBA 10/2016 - 01/2016
2	SteroidsIBA 01/2016 - 04/2015
2	Estrogen Receptor betaIBA 02/2014 - 08/2012
2	MitogensIBA 01/2014 - 09/2010
2	Nandrolone (Nortestosterone)IBA 11/2012 - 05/2012
2	Stanozolol (Winstrol)FDA Link 11/2012 - 05/2012
2	Insulin-Like Growth Factor I (IGF-1)IBA 11/2012 - 05/2012
2	AcidsIBA 10/2012 - 07/2011
2	Chenodeoxycholic Acid (Chenix)FDA Link 07/2012 - 02/2010
2	Rosiglitazone (Avandia)FDA Link 07/2011 - 09/2009
2	Cyclic AMP (AMP, Cyclic)IBA 03/2009 - 04/2007
2	ChromatinIBA 03/2009 - 04/2007
2	Carrier Proteins (Binding Protein)IBA 03/2009 - 04/2007
1	Mitogen-Activated Protein KinasesIBA 09/2021
1	Angiotensin IIIBA 09/2021
1	Losartan (Cozaar)FDA LinkGeneric 09/2021
1	B7-H1 AntigenIBA 09/2021
1	ResveratrolIBA 07/2021
1	PolyphenolsIBA 07/2021
1	gallocatechol (epigallocatechin)IBA 07/2021
1	LipopolysaccharidesIBA 07/2021
1	Biomarkers (Surrogate Marker)IBA 03/2021
1	Transcription Factors (Transcription Factor)IBA 09/2020
1	Monomeric GTP-Binding ProteinsIBA 08/2020
1	rab GTP-Binding ProteinsIBA 08/2020
1	Lipid Bilayers (Lipid Bilayer)IBA 08/2020
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 03/2020
1	Fish OilsIBA 03/2020
1	Serotonin (5 Hydroxytryptamine)IBA 03/2020
1	AmidesIBA 03/2020
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2020

Therapy/Procedure

19	Therapeutics 01/2022 - 02/2010
2	Mediterranean Diet 02/2022 - 07/2021
1	Precision Medicine 01/2022
1	Molecular Targeted Therapy 08/2020